JK
Jason R Kelly (See remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ginkgo Bioworks Holdings, Inc. (DNA). The largest single filing was $1.4M of DNA (206,782 sh across 2 lots, as filed), executed Apr 8. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.8M
shares × price, as filed
Last traded
Oct 19
Filed Oct 21
Median ADV $20.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DNARecent filings
DNASALE
Ginkgo Bioworks Holdings, Inc.
View filing →
$463K45,682 sh × $10.14
Exec Oct 19
Filed Oct 21 · 4:05 PM ET DNASALE Ginkgo Bioworks Holdings, Inc. View filing → $1.4M
206,782 sh across 2 lots
Exec Apr 8
Filed Apr 10 · 5:30 PM ET